Private Label Food Compliance: Who Owns the Final Label Review?

In private label food production, label compliance errors are almost always preceded by the same root cause: nobody clearly owned the final review. When brand owners, contract manufacturers, brokers, and retailers each assume someone else checked the label, undeclared allergens and false claims end up on store shelves.

Why Accountability Gaps Are a Private Label Problem Specifically

Branded manufacturers typically have internal QA teams, legal review, and R&D sign-off baked into their launch process. Private label supply chains are structurally different. You may have a retailer specifying the product, a broker coordinating sourcing, a co-packer producing and packaging it, and a brand owner whose name appears on the label — none of whom are physically in the same room, and often none of whom have a written agreement about who reviews what before production starts.

Under FDA regulations, the legal responsibility is unambiguous: the brand owner — the party whose name and address appear on the label under 21 CFR 101.5 — is responsible for label accuracy. That means if a co-packer lists the wrong allergen statement, or a broker submits an outdated formula to the printer, the brand owner bears the regulatory and legal exposure. FDA doesn't pursue the party who made the mistake. FDA pursues the party whose name is on the package.

That legal reality is often disconnected from how private label deals actually get structured. Brand owners frequently rely on manufacturers to "handle compliance" without specifying what that means in writing. The result is a chain of assumptions — and assumptions are how recalls happen. The FDA's recall database includes dozens of private label products recalled each year for undeclared allergens, net weight violations, and label claims that don't match the formula. Most of those recalls share the same origin story: no formal pre-launch label review protocol.

The Four-Party Accountability Map

Before you can fix your review process, you need to map who is doing what — and where the gaps are. Here's how responsibilities typically break down, and where each party most commonly fails.

Brand Owner / Private Label Licensee

This is the entity whose name appears on the label. Under 21 CFR 101.5(d), they are the "responsible party" for labeling accuracy. Their core obligations include:

• Verifying that the ingredient statement on the label matches the current formula used in production
• Confirming all allergens declared under FALCPA (the Food Allergen Labeling and Consumer Protection Act of 2004) are complete and accurate
• Ensuring any nutrient content claims or health claims comply with 21 CFR Part 101
• Reviewing net weight declarations against 21 CFR 101.105 and NIST Handbook 133 tolerances
• Retaining final label approval authority before any production run

Common failure point: Brand owners often approve artwork based on aesthetics, not compliance. A label can look correct and still contain a formula mismatch or missing "Contains" statement.

Contract Manufacturer / Co-Packer

The manufacturer controls the actual formula and production environment. Their compliance obligations include:

• Providing an accurate, current Bill of Materials (BOM) or ingredient specification sheet to the brand owner before label finalization
• Disclosing all allergens present in the facility, including shared equipment and cross-contact risks
• Notifying the brand owner of any formula or ingredient supplier changes that affect labeling — this is a formal FSMA Supply Chain requirement under 21 CFR Part 117
• Maintaining supplier documentation (SDS sheets, allergen declarations, COAs) for every ingredient

Common failure point: Co-packers substitute ingredients without notifying brand owners, particularly when a supplier goes out of stock. A flavor swap or starch change can introduce an undeclared allergen overnight.

Broker / Intermediary

Brokers facilitate the relationship between brand owner and manufacturer, but rarely have formal compliance obligations in writing. This is precisely where accountability evaporates.

• Brokers should not be the primary conduit for formula or label documentation — they should facilitate, not own, compliance review
• Any formula specifications or label copy passed through a broker must be version-controlled and confirmed by both the manufacturer and brand owner directly

Common failure point: Brokers pass outdated specs between parties without tracking document versions. A label gets printed against a formula from six months ago.

Retailer

Retailers who source private label products have a stake in compliance, but under FDA regulations, they are not the responsible label party unless their name appears on the package. However, sophisticated retailers increasingly require:

• Pre-submission label review as part of the vendor onboarding process
• Allergen questionnaires and COA documentation from manufacturers
• Third-party audit requirements or GFSI certification from co-packers

Common failure point: Retailers assume their vendor qualification process substitutes for a label review. Vendor approval is not label approval.

A Pre-Launch Label Review Workflow That Actually Works

The following workflow assigns clear checkpoints to the right parties before any label goes to print. Adapt it to your supply chain structure, but don't skip steps.

Step 1 — Formula Lock (Co-Packer Responsibility)

Before label design begins, the co-packer issues a finalized, signed BOM listing every ingredient, sub-ingredient, and supplier. This document must be version-controlled with a date stamp. Any subsequent formula change requires a new BOM and restarts the label review clock.

Step 2 — Allergen Cross-Reference (Shared: Brand Owner + Co-Packer)

The brand owner maps every ingredient in the BOM against the nine major allergens defined by FASTER Act (2023 update to FALCPA): milk, eggs, fish, shellfish, tree nuts, peanuts, wheat, soybeans, and sesame. The co-packer confirms facility-level cross-contact risks in writing. Both parties sign off.

Step 3 — Label Artwork Review (Brand Owner Responsibility)

This is where most private label programs are weakest. The brand owner — not the designer, not the broker — must compare the final label artwork against the locked BOM line by line. Specifically:

• Does the ingredient list on the label match the BOM exactly, including sub-ingredients?
• Is the "Contains" statement complete and correctly ordered?
• Are any nutrient content claims ("low sodium," "good source of fiber") supported by the nutrition facts panel?
• Does the net weight match the intended fill weight and package size?
• Is the manufacturer name and address current and correct under 21 CFR 101.5?

If you want to see what a structured pre-launch label review actually looks like in practice, view the annotated RecallGuard sample report — it walks through how each of these checkpoints gets flagged and documented on a real SKU review.

Step 4 — Regulatory Claims Verification (Brand Owner Responsibility)

Any front-of-pack claim — "natural," "no artificial flavors," "gluten-free," "non-GMO" — must be validated against the formula and applicable FDA definitions. "Gluten-free" has a specific regulatory threshold (less than 20 ppm) under 21 CFR 101.91. "Natural" has informal FDA guidance but no formal definition, which creates litigation exposure even when the claim isn't technically illegal.

Step 5 — Pre-Production Sign-Off (All Parties)

Before any production run begins, the brand owner issues a written label approval that references the specific BOM version, label version, and production date. This document should be retained as part of your FSMA records under 21 CFR Part 117. If the co-packer changes anything after sign-off — an ingredient, a supplier, a package size — production stops until a new review cycle is completed.

The Document You Need Before Every Launch

If your current process doesn't produce a written, dated, version-controlled label approval document signed by the brand owner before production, you don't have a label review process — you have an assumption. The document doesn't need to be complex. It needs to confirm:

1. BOM version reviewed and date
2. Label artwork version reviewed and date
3. Allergen cross-reference completed (yes/no)
4. Regulatory claims verified (list each claim)
5. Net weight verified
6. Reviewer name and title
7. Approval date and signature

That's it. Seven fields. The absence of this document is what transforms an ingredient substitution at the co-packer into a Class I recall.

If you're unsure whether your current label review process would catch the types of errors that trigger FDA recalls, the 85-second RecallGuard walkthrough shows how a structured SKU review is conducted and what gets flagged — worth 85 seconds before your next launch.

Closing the Accountability Gap

Private label compliance doesn't fail because people don't care. It fails because the org chart of a private label deal doesn't naturally create a single point of accountability. The brand owner needs to actively claim that role — in writing, with a documented process — rather than assuming the co-packer or broker has it covered.

If you're launching a new private label SKU and haven't formally locked down who owns each review step, that's the gap worth closing before your product ships. A pre-launch single SKU review ($349) covers label/formula alignment, allergen declaration accuracy, regulatory claim verification, and supplier documentation gaps — the exact checkpoints where private label products most commonly fail.